1-5 of 5
Bulent Aydogan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial

Lucas Maahs, Matthew Koshy, Karen Sweiss, Kang-hyun Ahn, Zhengjia Chen, Chukwuemeka Uzoka, Carlos Galvez, Paul Rubinstein, John Quigley, Santosh L. Saraf, Ana Maria Avila Rodriguez, Bulent Aydogan, Nadim Mahmud, Damiano Rondelli
Journal: Blood
Blood (2023) 142 (Supplement 1): 4897.
https://doi.org/10.1182/blood-2023-179270
Published: 2023
Journal Articles

Phase I Trial of a Novel Conditioning Regimen Utilizing Total Marrow Irradiation (TMI) with Fludarabine-Melphalan for Patients with Relapsed Hematologic Malignancies Undergoing Second Allogeneic Stem Cell Transplantation (Allo-SCT)

Hongtao Liu, MD PhD, Bulent Aydogan, MD, Yasmin Hasan, MD, Amy Wang, MD MPH, Kamil Yenice, MD, Julien Partouche, MD, Wendy Stock, MD, Richard A. Larson, MD, Satyajit Kosuri, MD, James LaBelle, MD PhD, Justin Kline, MD, Peter A. Riedell, MD, Andrew S. Artz, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-138554
Published: 2020
Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD
Journal: Blood
Blood (2016) 128 (22): 4646.
https://doi.org/10.1182/blood.V128.22.4646.4646
Published: 2016
Journal Articles

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Nadim Mahmud, MD, PhD, David Peace, MD, John G. Quigley, MD, Santosh L. Saraf, MD, Enzo DeMasi, MD, Ralph R Weichselbaum, MD, Damiano Rondelli, MD
Journal: Blood
Blood (2013) 122 (21): 3285.
https://doi.org/10.1182/blood.V122.21.3285.3285
Published: 2013
Journal Articles

Linac Based Total Marrow Irradiation and Myeloablative Chemotherapy In Allogeneic Stem Cell Transplantation for High Risk Patients.

Pritesh R. Patel, MB, ChB, Bulent Aydogan, PhD, Damiano Rondelli, MD
Journal: Blood
Blood (2010) 116 (21): 4526.
https://doi.org/10.1182/blood.V116.21.4526.4526
Published: 2010